E-LIB Suche - Ergebnisse für: Gordon, Kenneth J.

1

Ethylene Electrosynthesis via Selective CO2 Reduction: Fund..:

O' Carroll, Thomas ; Yang, Xiaoxuan ; Gordon, Kenneth J...
Advanced Energy Materials. , 2024

2

Effect of Spesolimab on Achieving Sustained Disease Remissi..:

Gordon, Kenneth ; Lebwohl, Mark ; Barker, Jonathan...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s357 , 2024

Link: https://doi.org/10.25251..

3

Effect of Subcutaneous Spesolimab on the Prevention of Gene..:

Warren, Richard ; Burden, David ; Choon, Siew Eng...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s245 , 2023

Link: https://doi.org/10.25251..

4

Carbonitride MXenes: An innovative catalyst support for sus..:

Gordon, Kenneth J. ; Zhou, Xiao-Dong ; Fei, Ling
Chem Catalysis. 3 (2023) 6 - p. 100664 , 2023

Link: https://doi.org/10.1016/..

5

Effects of Carbon Templates in Tetraethyl Orthosilicate-Der..:

Goulas, Joshua ; He, Zizhou ; Wortman, Philip...
Langmuir. , 2023

Link: https://doi.org/10.1021/..

6

44007 Risankizumab Long-Term Safety in Patients With Psoria..:

Gordon, Kenneth ; Blauvelt, Andrew ; Coates, Laura C....
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB219 , 2023

Link: https://doi.org/10.1016/..

7

Effect of Spesolimab on Achieving Sustained Disease Remissi..:

Gordon, Kenneth ; Conrad, Curdin ; Lebwohl, Mark...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s247 , 2023

Link: https://doi.org/10.25251..

8

The Epidemiology of Palmoplantar Pustulosis: An Analysis of..:

Ramcharran, Darmendra ; Strober, Bruce ; Gordon, Kenneth...
Advances in Therapy. 40 (2023) 11 - p. 5090-5101 , 2023

Link: https://doi.org/10.1007/..

9

Maintenance of Clinical Response With Continued Risankizuma..:

Lebwohl, Mark ; Bachelez, Hervé ; Gordon, Kenneth...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s258 , 2023

Link: https://doi.org/10.25251..

10

Molecular and clinical effects of selective tyrosine kinase..:

Catlett, Ian M. ; Hu, Yanhua ; Gao, Lu...
Journal of Allergy and Clinical Immunology. 149 (2022) 6 - p. 2010-2020.e8 , 2022

Link: https://doi.org/10.1016/..

11

Deucravacitinib in plaque psoriasis: 2-year laboratory resu..:

Korman, Neil ; Passeron, Thierry ; Gordon, Kenneth...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s46 , 2022

Link: https://doi.org/10.25251..

12

Deucravacitinib Improves Psoriasis Symptoms and Signs Diary..:

Armstrong, April ; Strober, Bruce ; Gordon, Kenneth...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 6 - p. s38 , 2021

Link: https://doi.org/10.25251..

13

Coordination Polymers in Dicyanamido-Cadmium(II) with Diver..:

Mautner, Franz A. ; Jantscher, Patricia V. ; Fischer, Roland C....
Crystals. 11 (2021) 2 - p. 181 , 2021

Link: https://doi.org/10.3390/..

14

27464 Bimekizumab vs adalimumab in plaque psoriasis: Higher..:

Blauvelt, Andrew ; Thaçi, Diamant ; Papp, Kim A....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB146 , 2021

Link: https://doi.org/10.1016/..

15

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2..:

Thaci, Diamant ; Gordon, Kenneth ; Gooderham, Melinda...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 6 - p. s37 , 2021

Link: https://doi.org/10.25251..